Healthcare Of Ontario Pension Plan Trust Fund Fate Therapeutics Inc Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$40.7 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 13, 2023	SELL	$2.02 - $5.04 $30,300 - $75,600	-15,000 Reduced 3.27%	444,038 $941,000
Q2 2023 Aug 11, 2023	BUY	$4.76 - $6.59 $2.19 Million - $3.03 Million	459,038 New	459,038 $2.19 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$35.3 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$27.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$27.1 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$14.9 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$14.1 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $260M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account